J. Reiffers et al., Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells, LANCET, 354(9184), 1999, pp. 1092-1093
Citations number
5
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
We show that absolute and severe neutropenia after high-dose therapy with m
elphalan with or without total body irradiation can be abrogated by cells g
enerated ex vivo. This may change the clinical practice of haematopoietic c
ell transplantation and high-dose chemotherapy because the morbidity and ho
spitalisation associated with neutropenia could be avoided or reduced.